Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIDEX for Post-Operative Pain in Bariatric Surgery
NCT07073846Phase 4Recruiting
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Oct 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine, dexmedetomidine in postoperative pain, post-operative inflammation, sponsored by Instituto Mexicano del Seguro Social. Started Oct 2025; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT07073846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07073846.